Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial
Eric J. Sherman, Jonathan Harris, Keith C. Bible, Ping Xia, Ronald A. Ghossein, Christine H. Chung, Nadeem Riaz, G. Brandon Gunn, Robert L. Foote, Sue S. Yom, Stuart J. Wong, Shlomo A. Koyfman, Michael F. Dzeda, David A. Clump, Saad A. Khan, Manisha H. Shah, Kevin Redmond, Pedro A. Torres-Saavedra, Quynh Thu Le, Nancy Y. Lee
Dive into the research topics of 'Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial'. Together they form a unique fingerprint.